Non-Invasive Prenatal Testing (NIPT) has emerged as a crucial tool in prenatal care, offering a safer alternative to traditional invasive methods for detecting genetic disorders. This article reviews recent advancements in NIPT technology, focusing on its effectiveness, accuracy, and broader applications. NIPT primarily screens for chromosomal abnormalities such as Down syndrome, but recent developments have expanded its capabilities to detect single-gene disorders and other genetic anomalies. The review highlights the improvements in sequencing technologies and bioinformatics tools that have enhanced the sensitivity and specificity of NIPT, reducing the need for confirmatory invasive procedures. **Key Takeaways: ** 1. Improved Accuracy: Advances in sequencing technologies have significantly increased the accuracy of NIPT, making it a reliable option for early detection of genetic disorders. 2. Broader Applications: NIPT is now capable of screening for a wider range of genetic conditions, beyond chromosomal abnormalities. 3. Reduced Risks: As a non-invasive method, NIPT reduces the risk of miscarriage associated with traditional invasive tests like amniocentesis. Challenges: Despite its benefits, NIPT faces challenges such as ethical considerations, cost, and accessibility issues, which need addressing to ensure equitable healthcare delivery.